Literature DB >> 22253024

Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE.

Angela Midgley1, Colin Thorbinson, Michael W Beresford.   

Abstract

OBJECTIVES: Toll-like receptors (TLRs) essential in the functioning of the immune system have been implicated in the development of autoimmunity. TLR3, 7, 8 and 9 are capable of recognizing nucleic autoantigens typical of SLE. Their expression correlates positively with disease activity in adult-onset SLE. This study aimed to determine the role of TLRs in JSLE and whether apoptotic neutrophils are a source of nuclear autoantigen being detected through TLR3, 7, 8 and 9, leading to an inflammatory response.
METHODS: TLR3, 7, 8 and 9 mRNA and protein expression were measured in peripheral blood mononuclear cells (PBMCs) in JSLE patients compared with JIA and non-inflammatory controls. Activation of the TLRs by JSLE serum-induced apoptotic neutrophils was detected by measuring IFN-α mRNA and protein expression, and confirmed using myeloid differentiation factor 88 (MyD88) and TIR domain-containing adapter-inducing IFN-β (TRIF) inhibitors.
RESULTS: JSLE patients have increased TLR3, 8 and 9 mRNA and protein expression compared with controls (P < 0.05). Incubation of PBMCs with apoptotic neutrophils demonstrated a dose-response relationship for IFN-α mRNA expression. Inhibition of TLR signalling by blocking MyD88 and TRIF signalling decreased IFN-α mRNA expression in PBMCs incubated with apoptotic neutrophils (P < 0.05).
CONCLUSIONS: This study demonstrated significantly increased TLR expression in JSLE compared with controls. Our data indicate that apoptotic neutrophils trigger TLR activation through their presentation of autoantigens. The role of TLRs in this inflammatory response was demonstrated by a dose-response relationship to apoptotic neutrophil concentration and confirmed by a decrease in IFN-α production after inhibition of TLR signalling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22253024     DOI: 10.1093/rheumatology/ker400

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

1.  The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients.

Authors:  Direkrit Chiewchengchol; Angela Midgley; Pimpayao Sodsai; Tawatchai Deekajorndech; Nattiya Hirankarn; Michael W Beresford; Steven W Edwards
Journal:  Clin Rheumatol       Date:  2014-10-26       Impact factor: 2.980

2.  Genetic polymorphisms of dsRNA ligating pattern recognition receptors TLR3, MDA5, and RIG-I. Association with systemic lupus erythematosus and clinical phenotypes.

Authors:  C Enevold; L Kjær; C H Nielsen; A Voss; R S Jacobsen; M L F Hermansen; L Redder; A B Oturai; P E Jensen; K Bendtzen; S Jacobsen
Journal:  Rheumatol Int       Date:  2014-04-10       Impact factor: 2.631

3.  Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice.

Authors:  Kelly D McCall; Jean R Thuma; Maria C Courreges; Fabian Benencia; Calvin B L James; Ramiro Malgor; Noriko Kantake; William Mudd; Nathan Denlinger; Bret Nolan; Li Wen; Frank L Schwartz
Journal:  Endocrinology       Date:  2014-11-25       Impact factor: 4.736

Review 4.  Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus.

Authors:  Colin Thorbinson; Louise Oni; Eve Smith; Angela Midgley; Michael W Beresford
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

5.  Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population.

Authors:  Chin-Man Wang; Su-Wei Chang; Yeong-Jian Jan Wu; Jing-Chi Lin; Huei-Huang Ho; Tse-Chih Chou; Bing Yang; Jianming Wu; Ji-Yih Chen
Journal:  Sci Rep       Date:  2014-01-21       Impact factor: 4.379

Review 6.  Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus.

Authors:  Steve P Crampton; Peter A Morawski; Silvia Bolland
Journal:  Dis Model Mech       Date:  2014-09       Impact factor: 5.758

Review 7.  U1-RNP and TLR receptors in the pathogenesis of mixed connective tissue diseasePart I. The U1-RNP complex and its biological significance in the pathogenesis of mixed connective tissue disease.

Authors:  Agnieszka Paradowska-Gorycka
Journal:  Reumatologia       Date:  2015-05-18

Review 8.  B Cells as a Therapeutic Target in Paediatric Rheumatic Disease.

Authors:  Meredyth G Ll Wilkinson; Elizabeth C Rosser
Journal:  Front Immunol       Date:  2019-02-14       Impact factor: 7.561

9.  Interferons (IFN-A/-B/-G) Genetic Variants in Patients with Mixed Connective Tissue Disease (MCTD).

Authors:  Agnieszka Paradowska-Gorycka; Anna Wajda; Barbara Stypinska; Ewa Walczuk; Marcela Walczyk; Anna Felis-Giemza; Aleksandra Poluch; Marzena Olesińska
Journal:  J Clin Med       Date:  2019-11-21       Impact factor: 4.241

10.  MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus.

Authors:  Yun Deng; Jian Zhao; Daisuke Sakurai; Kenneth M Kaufman; Jeffrey C Edberg; Robert P Kimberly; Diane L Kamen; Gary S Gilkeson; Chaim O Jacob; R Hal Scofield; Carl D Langefeld; Jennifer A Kelly; Rosalind Ramsey-Goldman; Michelle A Petri; John D Reveille; Luis M Vilá; Graciela S Alarcón; Timothy J Vyse; Bernardo A Pons-Estel; Barry I Freedman; Patrick M Gaffney; Kathy Moser Sivils; Judith A James; Peter K Gregersen; Juan-Manuel Anaya; Timothy B Niewold; Joan T Merrill; Lindsey A Criswell; Anne M Stevens; Susan A Boackle; Rita M Cantor; Weiling Chen; Jeniffer M Grossman; Bevra H Hahn; John B Harley; Marta E Alarcόn-Riquelme; Elizabeth E Brown; Betty P Tsao
Journal:  PLoS Genet       Date:  2013-02-28       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.